Catalyst Pharmaceuticals
CPRX
#3870
Rank
NZ$4.29 B
Marketcap
$36.03
Share price
-0.14%
Change (1 day)
58.39%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): NZ$0.15 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.43 Billion. In 2023 the company made an earning of NZ$0.16 Billion a decrease over its 2022 earnings that were of NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.15 B-6.5%
2023 NZ$0.16 B-9.75%
2022 NZ$0.17 B98.83%
2021 NZ$89.85 M25.73%
2020 NZ$71.46 M25.38%
2019 NZ$56.99 M-198.25%
2018 -NZ$58.02 Million84.68%
2017 -NZ$31.42 Million1.88%
2016 -NZ$30.84 Million-10.68%
2015 -NZ$34.52 Million30.46%
2014 -NZ$26.47 Million27.6%
2013 -NZ$20.74 Million198.17%
2012 -NZ$6.96 Million-36.22%
2011 -NZ$10.91 Million59.52%
2010 -NZ$6.84 Million-44.68%
2009 -NZ$12.36 Million-31.45%
2008 -NZ$18.03 Million155.21%
2007 -NZ$7.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.66 B 318.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.10 B-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.38 B 19,560.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.47 Billion-390.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$2.07 Billion-1,395.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.56 B 7,144.32%๐Ÿ‡บ๐Ÿ‡ธ USA